These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 33380662)

  • 1. Demographic and clinicopathological profile of patients of gastrointestinal stromal tumor from a tertiary care center of North India: An observational study.
    Aggarwal M; Aggarwal A; Arora S; Rathi AK; Singh K
    J Cancer Res Ther; 2020 Dec; 16(Supplement):S104-S109. PubMed ID: 33380662
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advanced gastrointestinal stromal tumors: 10-years experience from a tertiary care centre.
    Iqbal N; Sharma A; Shukla N; Mohanti BK; Deo SV; Sahni P; Pal S; Pathy S; Raina V; Kumar L
    Trop Gastroenterol; 2015; 36(3):168-73. PubMed ID: 27522735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Analysis of gastric gastrointestinal stromal tumors in Shandong Province: a midterm report of multicenter GISSG1201 study].
    Hou Q; Luo W; Li L; Dai Y; Jiang L; Wang A; Chu X; Li Y; Yang D; Lu C; Yao L; Cui G; Lin H; Chen G; Cui Q; Zhang H; Lun Z; Xia L; Su Y; Han G; Hui X; Wei Z; Sun Z; Guo H; Zhou Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Sep; 20(9):1025-1030. PubMed ID: 28900994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Current status of surgical treatment of gastric gastrointestinal tumors: a national multi-center retrospective study].
    Feng X; Li R; Zhang P; Chen T; Qiu H; Zhou Y; Du C; Yin X; Pan F; Zheng G; Sun X; Yu J; Chen Z; Zhao Y; Liu X; Li J; Zhang B; Zhou Y; Huang C; Zhou Z; Li G; Tao K; Li Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2016 Nov; 19(11):1258-1264. PubMed ID: 27928796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathologic Complete Response in a Large Gastric GIST: Using Molecular Markers to Achieve Maximal Response to Neoadjuvant Imatinib.
    Brown JB; Pai RK; Burgess MA; Chennat J; Zureikat AH
    J Natl Compr Canc Netw; 2018 Dec; 16(12):1424-1428. PubMed ID: 30545989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and Tolerability of 5-Year Adjuvant Imatinib Treatment for Patients With Resected Intermediate- or High-Risk Primary Gastrointestinal Stromal Tumor: The PERSIST-5 Clinical Trial.
    Raut CP; Espat NJ; Maki RG; Araujo DM; Trent J; Williams TF; Purkayastha DD; DeMatteo RP
    JAMA Oncol; 2018 Dec; 4(12):e184060. PubMed ID: 30383140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic analysis of patients with gastrointestinal stromal tumors: a single unit experience with surgical treatment of primary disease.
    Cao H; Zhang Y; Wang M; Shen DP; Sheng ZY; Ni XZ; Wu ZY; Liu Q; Shen YY; Song YY
    Chin Med J (Engl); 2010 Jan; 123(2):131-6. PubMed ID: 20137358
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Changes of diagnosis and treatment for gastrointestinal stromal tumors during a 18-year period in four medical centers of China].
    Qiu H; Zhang P; Feng X; Chen T; Sun X; Yu J; Chen Z; Li Y; Tao K; Li G; Zhou Z
    Zhonghua Wei Chang Wai Ke Za Zhi; 2016 Nov; 19(11):1265-1270. PubMed ID: 27928797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Giant gastric gastrointestinal stromal tumor with severe peritoneal dissemination controlled by imatinib therapy following debulking surgery: a case report.
    Fukuda S; Fujiwara Y; Wakasa T; Kitani K; Tsujie M; Yukawa M; Ohta Y; Inoue M
    J Med Case Rep; 2017 Feb; 11(1):33. PubMed ID: 28166823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Analysis of imatinib trough concentration at steady state in adjuvant therapy of patients with high risk gastrointestinal stromal tumor].
    Wan WZ; Zhang P; Zeng XY; Zhou H; Lin Y; Xiong Z; Zhang RZ; Liu WZ; Han Y; Tao KX
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Sep; 22(9):848-855. PubMed ID: 31550824
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical and pathological characteristics and their effect on survival in elderly patients with gastrointestinal stromal tumors.
    Molinas Mandel N; Selcukbiricik F; Kanitez M; Yalcin S; Tural D; Erdamar S; Dogusoy G; Demir G
    J BUON; 2016; 21(2):360-5. PubMed ID: 27273945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary Gastrointestinal Stromal Tumor Mimicking as Gynecologic Mass: Characteristics, Management, and Prognosis.
    Tao K; Zeng X; Liu W; Wang S; Gao J; Shuai X; Zhang P
    J Surg Res; 2020 Feb; 246():584-590. PubMed ID: 31653414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of clinicopathological and immunohistochemical parameters and correlation of outcomes in gastrointestinal stromal tumors.
    Varshney VK; Gupta RK; Saluja SS; Tyagi I; Mishra PK; Batra VV
    Indian J Cancer; 2019; 56(2):135-143. PubMed ID: 31062732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathologic and molecular features correlate with long-term outcome after adjuvant therapy of resected primary GI stromal tumor: the ACOSOG Z9001 trial.
    Corless CL; Ballman KV; Antonescu CR; Kolesnikova V; Maki RG; Pisters PW; Blackstein ME; Blanke CD; Demetri GD; Heinrich MC; von Mehren M; Patel S; McCarter MD; Owzar K; DeMatteo RP
    J Clin Oncol; 2014 May; 32(15):1563-70. PubMed ID: 24638003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical characteristics and prognosis analysis of 119 cases with giant gastrointestinal stromal tumor].
    Zhang P; Zeng X; Gao J; Liu W; Shuai X; Liu K; Liu X; Cai M; Cai K; Wang G; Tao K
    Zhonghua Wei Chang Wai Ke Za Zhi; 2016 Nov; 19(11):1290-1295. PubMed ID: 27928802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-Term Imatinib Treatment for Patients with Unresectable or Recurrent Gastrointestinal Stromal Tumors.
    Ogata K; Kimura A; Nakazawa N; Suzuki M; Yanoma T; Ubukata Y; Iwamatsu K; Kogure N; Yanai M; Kuwano H
    Digestion; 2018; 97(1):20-25. PubMed ID: 29393163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of neoadjuvant imatinib therapy on outcome and survival in rectal gastrointestinal stromal tumors: A multiinstitutional study.
    Yang W; Liu Q; Lin G; Zhang B; Cao H; Zhao Y; Xia L; Feng F; Xiong Z; Hu J; Ye Y; Tao K; Zhang P
    J Surg Oncol; 2021 Dec; 124(7):1128-1135. PubMed ID: 34324197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The analysis of 3-year adjuvant therapy with imatinib in patients with high-risk molecular profiled gastrointestinal stromal tumors (GIST) treated in routine practice.
    Rutkowski P; Ziętek M; Cybulska-Stopa B; Streb J; Głuszek S; Jankowski M; Łopacka-Szatan K; Las-Jankowska M; Hudziec P; Klimczak A; Olesiński T; Świtaj T; Koseła-Paterczyk H; Bylina E; Osuch C
    Eur J Surg Oncol; 2021 May; 47(5):1191-1195. PubMed ID: 32826113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of KIT and PDGFRA Mutations on Survival in Patients With Gastrointestinal Stromal Tumors Treated With Adjuvant Imatinib: An Exploratory Analysis of a Randomized Clinical Trial.
    Joensuu H; Wardelmann E; Sihto H; Eriksson M; Sundby Hall K; Reichardt A; Hartmann JT; Pink D; Cameron S; Hohenberger P; Al-Batran SE; Schlemmer M; Bauer S; Nilsson B; Kallio R; Junnila J; Vehtari A; Reichardt P
    JAMA Oncol; 2017 May; 3(5):602-609. PubMed ID: 28334365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surgical Treatment of Gastrointestinal Stromal Tumors Located in the Stomach in the Imatinib Era.
    Stiekema J; Kol S; Cats A; Yazdi AT; van Coevorden F; van Sandick JW
    Am J Clin Oncol; 2015 Oct; 38(5):502-7. PubMed ID: 24064754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.